The Competitive Edge for
Every Government Program Strategy
Market, product, network, and forecast intelligence — all in one platform.
Updated within 12 hours of every CMS release.
ProductIntel™
Know what every competitor is offering, benefit by benefit, plan by plan. Parsed from 5,000+ EOC documents to give you an edge in the market.
NetworktIntel™
See exactly where your network is stronger or weaker than every competitor in your market, down to the individual provider.
MarketIntel™
Track enrollment shifts, competitor moves, and market share changes across every county you operate in. Spot opportunities easily.
Latest Insights from HealthworksAI
Discover original research, competitive analysis, and strategic intelligence
from the HealthWorksAI team — tested against 1,400+ markets.
Minnesota’s ~500K+ member MA market is shifting to provider-integrated regional plans
The 8 largest non-SNP payers, the fastest-growing D-SNP and C-SNP plans, the key AEP cost versus benefit trade-offs driving member choice, and what these trends mean for your bids, Star Ratings, and provider network strategy.
Florida just proved quality beats volume. Here’s exactly who won.
The 8 largest non-SNP payers, the D-SNP/C-SNP plans moving fastest, and the AEP cost & benefit trade-offs behind them — plus what it means for your bid, your Stars, and your network.
Q2 2026 Earnings, the competitive view
MA strategy has converged around margin over membership, UnitedHealth and CVS are both deliberately trading enrollment for margin, while Humana and Alignment are the visible outliers still guiding double-digit MA growth.
CVS Q2 2026 Earnings Analysis
Alignment Healthcare’s Q2 2026 earnings beat guidance across the board, yet shares fell as second-half margin cadence weakens.
Alignment Healthcare, Inc. Q2 2026 Earnings Analysis
Alignment Healthcare’s Q2 2026 earnings beat guidance across the board, yet shares fell as second-half margin cadence weakens.
Humana Inc. Q2 2026 Earnings Analysis
Humana beat Q2 2026 earnings estimates, but cut full-year GAAP EPS guidance again as Star Ratings costs and thinning reserves offset the win.